Patient Story
A year later, ‘a lot better’
Phil Simon had reached the end of the line with existing multiple sclerosis medications. A year after starting a new drug, his walking and stamina have improved.
Phil Simon had reached the end of the line with existing multiple sclerosis medications. A year after starting a new drug, his walking and stamina have improved.
At a critical point in the progression of his multiple sclerosis, a local chef pins his hopes on a breakthrough medication.